By IDSE News Staff
A global wave of infections caused by multidrug-resistant (MDR) fungi will require a conserted effort to improve patient care (Pathog Immun 2024;8[2]:158-176).
Epidemiological data indicate that a rise in severe fungal infections has resulted in more than 150 million cases annually and almost 1.7 million fatalities globally (Microb Cell 2020;7[6]:143-145).
“This is not just an issue that affects individual patients,” explained Thomas McCormick, PhD, a professor of